July 31, 2019 (CAMBRIDGE, MA) – The Massachusetts Biotechnology Council (MassBio®) today announced its luminary lineup of speakers for the Digital Health Impact 2019 conference that will make its debut on Monday, September 9, 2019, on Opening Day of Biotech Week Boston.
“This conference is part of an overall digital health strategy MassBio put in place to support digital transformation in the life sciences, so that biopharma and medtech companies can truly benefit from digital technologies and enhance their research capabilities to improve patient care,” said Robert K. Coughlin, President and CEO of MassBio. “We are thrilled to offer up some of the brightest minds in digital health, biotech, and medtech to explore new strategies for convergence.”
DIGITAL HEALTH IMPACT 2019 FEATURED SPEAKERS
Keynote Address: “What is Digital Health and Where are We Headed?” delivered by John Nosta, #1 Global Influencer in Digital Health, Google Health Advisory Board, Fortune Magazine, NostaLab Think Tank
Possible Talk: Amitabh Chandra, Ph.D., Harvard Kennedy School – “Digital Health Economics – Are we Willing to Pay for Future Success?”
Luba Greenwood, Dana Farber: Moderator, Panel Discussion – “Turning Data into Actionable Insights…Is Data the New Oil?”
Panel Speakers: Piali De, Ph.D., Cofounder and CEO, Senscio Systems; Jay Desai, Cofounder and CEO, Patient Ping; Hans Constandt Founder and CEO, Ontoforce; and Iya Khalil, Ph.D., COO, GNS Health
Luncheon Keynote: “Constructing a New Kind of Healthcare System” delivered by John Halamka, M.D., CIO, Beth Israel Lahey Health, International Healthcare Professor, Harvard Medical School
Fireside Chat: “What it Really Takes to Become a Digital Health Founder” with Tanzeem Choudhury, Ph.D., Cofounder and CEO, HealthRhythms; and Bill Geary, Cofounder and Partner, Flare Capital Partners
Chrissy Farr, CNBC: Moderator, Panel Discussion – “How Digital Health is Improving Patient Outcomes & Reducing Healthcare Costs”
Panel Speakers: Grace Colon, Ph.D., CEO, InCarda; Yuri Maricich, M.D., CMO, Pear Therapeutics; Raolat Abdulai, M.D., Clinical Research Director, Sanofi; and Lesley Solomon, SVP & Chief Innovation Officer, Dana-Farber
Possible Talk: Mariya Filipova, VP of Innovation, Anthem – “Moving from Sickcare to Wellcare”
Closing Keynote: “What the CVS-Aetna Merger Means for Tracking Patient Outcomes and the Future of Healthcare,” delivered by Troyen Brennan, M.D., EVP & Chief Medical Officer, CVS Health
“MassBio is a valued partner and we look forward continuing to work with them and their members to make Massachusetts the best place in the world to start and grow a digital health company,” said Laurance Stuntz, Director, Massachusetts eHealth Institute at MassTech, the state agency leading Massachusetts' efforts to grow the digital health cluster. Stuntz is a member of Governor Baker's Mass Digital Health Council and a Steering Committee member of MassBio's Digital Health Initiative. “Digital Health Impact 2019 has developed an amazing program with many of the industry's foremost thought leaders who will shed light on the state of digital health here in Massachusetts and beyond.”
Digital Health Impact 2019 is the featured “Digital Health Showcase” at Biotech Week Boston, the annual festival of leading events spanning the entire drug development value chain. Deloitte, KCR, McDermott Will & Emery, Sunovion, and Wilmer Hale are sponsors of Digital Health Impact 2019. For additional sponsorship opportunities, contact Laura Rudberg and view the sponsorship prospectus here.
“We are thrilled to add Digital Health Impact 2019 to our festival of events,” said Tamsin Aspinall, Festival Director, Biotech Week Boston. “Digital Health is helping to drive the future of the life sciences, and we know attendees will want to take this opportunity to hear the latest on digital transformation from the top minds in the industry.”
Register to attend online: http://bit.ly/2Yb9M4r
About Digital Health Impact 2019
Digital Health Impact 2019 is the premier summit for biopharma companies looking to capitalize on the power of data and digital technologies in transforming their drug development and discovery, and ultimately, transforming patient care. In February of 2019, MassBio released its first digital health report and announced a new initiative aimed at ensuring digital health startups and their technologies have the best opportunity to converge with life sciences companies in the world-leading biotech supercluster. The impact of digital health is far reaching, from wearable gadgets and sensors that gather patient data, to mobile health apps which help people manage their own health, to artificial intelligence which helps researchers boost the success rate of clinical trials. For more info go to: http://bit.ly/2Yb9M4r
MassBio® is a not-for-profit organization founded in 1985 that represents and provides services and support for the world’s leading life sciences supercluster. MassBio is committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing 1,200+ biotechnology companies, academic institutions, disease foundations and other organizations involved in life sciences and healthcare, MassBio leverages its unparalleled network of innovative companies and industry thought leaders to advance policy and promote education, while providing member programs, events, industry information, and services. Learn more at https://www.massbio.org/ and stay connected on social media: Twitter, LinkedIn, and Facebook.